Home / Guidelines & Products

M11 – Clinical electronic Structured Harmonised Protocol (CeSHarP)

Guideline number: M11

This topic was endorsed by the ICH Management Committee in November 2018. This new guideline is proposed to provide comprehensive clinical protocol organisation with standardised content, with:

  • A Template which presents the format and structure of the protocol, including the table of contents, common headers, and contents;
  • A Technical Specification which presents the conformance, cardinality, and other technical attributes that enable the interoperable electronic exchange of protocol content.

The Technical Specification document and Template had reached Step 2b on 27 September 2022 and entered public consultation. They have been updated by the M11 EWG following the comments received. The Technical Specification is now being submitted for a second round of public consultations, and the Template is provided as a support to the consultation.

Guideline

Ongoing public consultations

No results found.

M11 Expert Working Group

Rapporteur

Dr. Veronica PeiFDA, United States

Regulatory Chair

Dr. Noemie ManentEC, Europe

Experts

ANVISA, BrazilMr. Claudio Nishizawa
BIODr. Mitzi Allred
CDSCO, IndiaMr. Jayant Kumar
EC, EuropeMs. Corinne Gagnet Kiger
EC, EuropeMs. Mumtaz Sultani
EFPIAMs. Geetha Subramanyam
EFPIADr. Guillaume Schoch
FDA, United StatesDr. Janice Maniwang
Health Canada, CanadaDr. Kathy Soltys
HSA, SingaporeMs. Diana Koh
IFPMAProf. Wenbin Li
IGBADr. Deven Parmar
JPMAMr. Manabu Inoue
JPMAMr. Hiroshi Matsuzawa
JPMAMr. Satoru Tsuchiya
MHLW/PMDA, JapanMr. Hiroshi Sakaguchi
MHLW/PMDA, JapanDr. Toshinori Takagi
National Center, KazakhstanMs. Akmaral Arzuova
NMPA, ChinaMr. Jianzhong Zhao
PhRMAMs. Tanya Fleege
PhRMADr. Mary Lynn Mercado
PhRMAMs. Antonia Valakas
SFDA, Saudi ArabiaMs. Marwa Alabbas
TFDA, Chinese TaipeiMs. Hui-Tzu Lin

Rapporteur Supporter

Ms. Tanya FleegePhRMA

Alternate

Ms. Maryangela Rezende Mascarenhas Santos MotaANVISA, Brazil
Chad IrwingHealth Canada, Canada
Kinga MichnoHealth Canada, Canada
Dr. Nan WangIFPMA
Dr. San-Shan ChangTFDA, Chinese Taipei

Related guidelines